A detailed history of Bridgeway Capital Management, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 139,200 shares of KOD stock, worth $1.16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
139,200
Previous 139,200 -0.0%
Holding current value
$1.16 Million
Previous $327,000 11.01%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.29 - $4.48 $57,250 - $112,000
25,000 Added 21.89%
139,200 $327,000
Q4 2023

Feb 14, 2024

BUY
$1.4 - $3.24 $159,880 - $370,008
114,200 New
114,200 $347,000
Q1 2020

May 15, 2020

SELL
$38.18 - $73.95 $381,800 - $739,500
-10,000 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$13.9 - $76.65 $34,750 - $191,625
-2,500 Reduced 20.0%
10,000 $720,000
Q2 2019

Aug 14, 2019

BUY
$6.2 - $12.0 $77,500 - $150,000
12,500 New
12,500 $146,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $433M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.